Colorectal Cancer Screening Intervention Trial
Research on Community Cancer Control: Study of Colorectal Cancer Screening in the African American Population
1 other identifier
interventional
360
1 country
1
Brief Summary
Colorectal cancer is the second deadliest among cancers and disproportionately affects African Americans. The Colorectal Cancer Screening Intervention Trial(CCSIT) project has as its goal to test three interventions designed to increase screening rates among medically underserved African Americans in the Metropolitan Atlanta area. It is designed to increase awareness of modifiable risk factors and promote the benefits of screening as a means of early detection of colorectal cancer. mportance of being screened for colorectal cancer,African Americans continue to be disproportionately affected by this disease. The Colorectal Cancer Screening
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Mar 2003
Longer than P75 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2003
CompletedFirst Submitted
Initial submission to the registry
December 13, 2005
CompletedFirst Posted
Study publicly available on registry
December 15, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedFebruary 4, 2009
February 1, 2009
4.3 years
December 13, 2005
February 3, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colorectal Cancer Screening Rate; This measurement(Impact) is taken 90 days from last intervention session. If a person is not screened, an additional measurement(Post-Impact) is taken 90 days from the Impact.
Secondary Outcomes (1)
Knowledge, Attitudes and Beliefs; this measurement is taken at baseline and post intervention session. Sessions vary by intervention group after the initial recruitment sessions:
Study Arms (4)
Control
PLACEBO COMPARATORWritten materials only
Reduced out-of-pocket expense
EXPERIMENTALReimbursed up to $500 out-of-pocket expense for colorectal cancer screening
One-on-one education
EXPERIMENTALIndividual education with a health educator on CRC screening
Group Education
EXPERIMENTALEducation on CRC screening in a small group with a health educator
Interventions
Reimbursed up to $500 out of pocket expense for CRC screening
Eligibility Criteria
You may qualify if:
- African American
- Previously not screened for colorectal cancer according to ACS guidelines
- Reside in Fulton,,Gwinett,Cobb,Clayton and DeKalb counties
- years of age or older
You may not qualify if:
- Non-African American
- Less than 50 years of age
- Previously screened consistent with ACS guideline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Morehouse School of Medicine
Atlanta, Georgia, 30310-1495, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Blumenthal, M.D., M.P.H.
Morehouse School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 13, 2005
First Posted
December 15, 2005
Study Start
March 1, 2003
Primary Completion
July 1, 2007
Study Completion
July 1, 2007
Last Updated
February 4, 2009
Record last verified: 2009-02